The effect of corticosteroids on quality of life in a sarcoidosis clinic: The results of a propensity analysis

Respiratory Medicine

Volumn 109, Issue 4, 2015, Pages 526-531

  Judson, Marc A ^a   Chaudhry, Haroon ^a   Louis, Amanda ^a   Lee, Kevin ^a   Yucel, Recai ^b  

^a ALBANY MEDICAL COLLEGE   (United States)

^b UNIVERSITY AT ALBANY   (United States)

Author keywords

Corticosteroids; Patient reported outcomes; Quality of life; Sarcoidosis

Indexed keywords

CORTICOSTEROID; PREDNISONE; ANTIINFLAMMATORY AGENT;

ADULT; ARTICLE; ASSESSMENT OF HUMANS; CONTROLLED STUDY; CORTICOSTEROID THERAPY; DISEASE SEVERITY; DRUG EFFECT; FEMALE; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; HUMAN; MAJOR CLINICAL STUDY; MALE; PATIENT SATISFACTION; PRIORITY JOURNAL; PROPENSITY SCORE; QUALITY OF LIFE; SARCOIDOSIS; SARCOIDOSIS ASSESSMENT TOOL; SARCOIDOSIS HEALTH QUESTIONNAIRE; SEX RATIO; SPIROMETRY; CARDIOMYOPATHIES; COMPLICATION; DAILY LIFE ACTIVITY; DOSE RESPONSE; FATIGUE; HEALTH DISPARITY; MIDDLE AGED; PATHOPHYSIOLOGY; PSYCHOLOGY; SARCOIDOSIS, PULMONARY; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME; UNITED STATES;

ACTIVITIES OF DAILY LIVING; ADRENAL CORTEX HORMONES; ADULT; ANTI-INFLAMMATORY AGENTS; CARDIOMYOPATHIES; DOSE-RESPONSE RELATIONSHIP, DRUG; FATIGUE; FEMALE; HEALTH STATUS DISPARITIES; HUMANS; MALE; MIDDLE AGED; PROPENSITY SCORE; QUALITY OF LIFE; SARCOIDOSIS; SARCOIDOSIS, PULMONARY; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME; UNITED STATES;

EID: 84925814006     PISSN: 09546111     EISSN: 15323064     Source Type: Journal    
DOI: 10.1016/j.rmed.2015.01.019     Document Type: Article

References (21)

1. G.W. Hunninghake, U. Costabel, and M. Ando ATS/ERS/WASOG statement on sarcoidosis. American Thoracic Society/European Respiratory Society/World Association of Sarcoidosis and other Granulomatous Disorders Sarcoidosis Vasc Diffuse Lung Dis 16 1999 149 173
2. M.A. Judson Sarcoidosis: clinical presentation, diagnosis, and approach to treatment Am J Med Sci 335 2008 26 33
3. R.P. Baughman, M.A. Judson, and A. Teirstein Presenting characteristics as predictors of duration of treatment in sarcoidosis Qjm 99 2006 307 315
4. R.P. Baughman, S. Nagai, and M. Balter Defining the clinical outcome status (COS) in sarcoidosis: results of WASOG task force Sarcoidosis Vasc Diffuse Lung Dis 28 2011 56 64
5. S.H. Beegle, K. Barba, and R. Gobunsuy Current and emerging pharmacological treatments for sarcoidosis: a review Drug Des Dev Ther 7 2013 325 338
6. C.E. Cox, J.F. Donohue, and C.D. Brown Health-related quality of life of persons with sarcoidosis Chest 125 2004 997 1004
7. M.A. Judson The diagnosis of sarcoidosis Clin Chest Med 29 2008 415 427 viii
8. C.E. Cox, J.F. Donohue, and C.D. Brown The Sarcoidosis Health Questionnaire: a new measure of health-related quality of life Am J Respir Crit Care Med 168 2003 323 329
9. D.E. Victorson, D. Cella, and H. Grund A conceptual model of health-related quality of life in sarcoidosis Qual Life Res 23 2014 1301 1313
10. D.E. Victorson, S. Choi, and M.A. Judson Development and testing of item response theory-based item banks and short forms for eye, skin and lung problems in sarcoidosis Qual Life Res 23 2014 1301 1313
11. M.A. Judson, R.P. Baughman, and A.S. Teirstein Defining organ involvement in sarcoidosis: the ACCESS proposed instrument. ACCESS Research Group. A Case Control Etiologic Study of Sarcoidosis Sarcoidosis Vasc Diffuse Lung Dis 16 1999 75 86
12. J.G. Scadding Prognosis of intrathoracic sarcoidosis in England. A review of 136 cases after five years' observation Br Med J 2 1961 1165 1172
13. D.E. Ho, K. Imai, and G. King MatchIt: nonparametric preprocessing for parametric causal inference J Stat Softw 42 2011 1 28
14. G.E. Westney, and M.A. Judson Racial and ethnic disparities in sarcoidosis: from genetics to socioeconomics Clin Chest Med 27 2006 453 462 vi
15. M.A. Judson, A.D. Boan, and D.T. Lackland The clinical course of sarcoidosis: presentation, diagnosis, and treatment in a large white and black cohort in the United States Sarcoidosis Vasc Diffuse Lung Dis 29 2012 119 127
16. M.A. Judson, M. Mack, and J.L. Beaumont Validation and important differences for the sarcoidosis assessment tool: a new patient reported outcome measure Am J Respir Crit Care Med 2015 [in press]
17. M.A. Judson An approach to the treatment of pulmonary sarcoidosis with corticosteroids: the six phases of treatment Chest 115 1999 1158 1165
18. R.P. Baughman, H. Nunes, and N.J. Sweiss Established and experimental medical therapy of pulmonary sarcoidosis Eur Respir J 41 2013 1424 1438
19. G.J. Gibson, R.J. Prescott, and M.F. Muers British Thoracic Society Sarcoidosis study: effects of long term corticosteroid treatment Thorax 51 1996 238 247
20. B.P. McKinzie, W.M. Bullington, and J.E. Mazur Efficacy of short-course, low-dose corticosteroid therapy for acute pulmonary sarcoidosis exacerbations Am J Med Sci 339 2010 1 4
21. C.J. Johns, and T.M. Michele The clinical management of sarcoidosis. A 50-year experience at the Johns Hopkins Hospital Med Baltim 78 1999 65 111